# Ulipristal Acetate in Symptomatic Uterine Fibroid

> **NCT04132349** · PHASE4 · TERMINATED · sponsor: **Mỹ Đức Hospital** · enrollment: 25 (actual)

## Conditions studied

- Uterine Fibroid
- Heavy Menstrual Bleeding

## Interventions

- **DRUG:** Ulipristal Acetate 5 mg

## Key facts

- **NCT ID:** NCT04132349
- **Lead sponsor:** Mỹ Đức Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-23
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Ulipristal Acetate was recalled
- **Last updated:** 2020-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04132349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04132349, "Ulipristal Acetate in Symptomatic Uterine Fibroid". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04132349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*